Criteria / Value
Criteria
Value
|
Grade | |
---|---|---|
Current dividend yield
1.52%
|
0/3 | |
Dividend Yield 10Y
3.03%
|
3/3 | |
Payout 3Y
70.41%
|
3/3 | |
Continuity 10Y
1 Year
|
0/3 | |
Growth 5Y
-4.04%
|
0/3 | |
No top scorer |
Total: 6/15
|
Year | Dividend | Ex-day & Payday |
Frequency | |
---|---|---|---|---|
Fiscal Year | Dividend per Share | Ex-Day | Payday | Payment frequency |
2024 |
GBP1
GBP1
|
Feb 20 2025
Feb 20 2025
Mar 24 2025
Feb 20 25
Mar 24 25 |
Mar 24 2025 |
-
-
|
2024 |
GBP0.776
GBP0.78
|
Aug 08 2024
Aug 08 2024
Sep 09 2024
Aug 08 24
Sep 09 24 |
Sep 09 2024 |
-
-
|
2023 |
GBP1
GBP1
|
Feb 22 2024
Feb 22 2024
Mar 25 2024
Feb 22 24
Mar 25 24 |
Mar 25 2024 |
-
-
|
2023 |
GBP0.718
GBP0.72
|
Aug 10 2023
Aug 10 2023
Sep 11 2023
Aug 10 23
Sep 11 23 |
Sep 11 2023 |
-
-
|
2022 |
GBP1.628
GBP1.63
|
Feb 23 2023
Feb 23 2023
Mar 27 2023
Feb 23 23
Mar 27 23 |
Mar 27 2023 |
-
-
|
2022 |
GBP0.764
GBP0.76
|
Aug 11 2022
Aug 11 2022
Sep 12 2022
Aug 11 22
Sep 12 22 |
Sep 12 2022 |
-
-
|
2021 |
GBP1.453
GBP1.45
|
Feb 24 2022
Feb 24 2022
Mar 28 2022
Feb 24 22
Mar 28 22 |
Mar 28 2022 |
-
-
|
2021 |
GBP0.648
GBP0.65
|
Aug 12 2021
Aug 12 2021
Sep 13 2021
Aug 12 21
Sep 13 21 |
Sep 13 2021 |
-
-
|
2020 |
GBP1.374
GBP1.37
|
Feb 25 2021
Feb 25 2021
Mar 29 2021
Feb 25 21
Mar 29 21 |
Mar 29 2021 |
-
-
|
2020 |
GBP0.696
GBP0.7
|
Aug 13 2020
Aug 13 2020
Sep 14 2020
Aug 13 20
Sep 14 20 |
Sep 14 2020 |
-
-
|
AstraZeneca most recently paid a dividend of GBP1.00. AstraZeneca paid a Dividend of GBP1.78 Per Share in the financial year 2024. With a stock price of GBP117.08 at Feb 21 2025, the current dividend yield is 1.52% (calculation: GBP1.78 / GBP117.08 = 1.52%). No special dividend was paid.
The average AstraZeneca dividend yield over the last 5 years is 2.19% and the average over the last 10 years is 3.03%.
The payout ratio of AstraZeneca in relation to the last financial year is 50.03%. The payout ratio smoothed over 3 years is 70.41%. The calculation is based on the sum of all dividend payments divided by the cumulative earnings per share(EPS).
Metric | AstraZeneca |
---|---|
Current dividend yield | 1.52% |
Dividend Yield 5Y | 2.19% |
Dividend Yield 10Y | 3.03% |
Payout 1Y | 50.03% |
Payout 3Y | 70.41% |
AstraZeneca has been paying a dividend for 25 years and has not reduced the dividend since 1 (dividend continuity). As a result, the dividend was recently increased 1-times.
The Dividend Growth in relation to the previous financial year amounts to 3.38%. The average AstraZeneca Dividend Growth over the last 5 years is -4.04%. The average for the last 10 years is 1.50%.
Metric | AstraZeneca |
---|---|
Increased | 1 Year |
Continuity | 1 Year |
Paid | 25 Years |
Growth 1Y | 3.38% |
Growth 5Y | -4.04% |
Growth 10Y | 1.50% |
AstraZeneca has been paying a dividend for 25 years and has not reduced the dividend since 1 (dividend continuity). As a result, the dividend was recently increased 1-times.
The Dividend Growth in relation to the previous financial year amounts to 3.38%. The average AstraZeneca Dividend Growth over the last 5 years is -4.04%. The average for the last 10 years is 1.50%.
On the stock exchange, the AstraZeneca stock (ISIN: GB0009895292) is not traded as a top scorer in February 2025 according to the dividend strategy.
The stock price of AstraZeneca 13.47% has risen since the beginning of the year 2025. However, the return generated in the past says nothing about the future return. You can find the AstraZeneca stock price in real time at the top of the page.
AstraZeneca (symbol: AZN) is valued at a Price / Earnings Ratio (P/E ratio) of 32.90 and a price/sales ratio (P/S ratio) of 4.29 valued. Based on analyst estimates, the AstraZeneca stock forecast 2025 of the current financial year corresponds to a valuation of 22.94 according to P/E ratio and 3.99 according to P/S.
Metric | AstraZeneca |
---|---|
Dividend Score | 6/15 |
Performance 2025 |
13.47%
|
P/E TTM | 32.90 |
P/S TTM | 4.29 |
P/E forward | 22.94 |
P/S forward | 3.99 |
AstraZeneca (symbol: AZN) is valued at a Price / Earnings Ratio (P/E ratio) of 32.90 and a price/sales ratio (P/S ratio) of 4.29 valued. Based on analyst estimates, the AstraZeneca stock forecast 2025 of the current financial year corresponds to a valuation of 22.94 according to P/E ratio and 3.99 according to P/S.
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.